At a glance
- Originator Pfizer
- Class
- Mechanism of Action Calcium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Irritable bowel syndrome
Most Recent Events
- 17 Jul 1998 No-Development-Reported for Irritable bowel syndrome in USA (Unknown route)
- 20 Sep 1995 Preclinical development for Irritable bowel syndrome in USA (Unknown route)